I now have rich, comprehensive content from multiple authoritative textbooks plus great diagrams. Let me compile the full answer.
Blood-Brain Barrier (BBB) - Anatomy
Historical Discovery
The BBB was first demonstrated by Paul Ehrlich in 1885 when he injected aniline dyes intravenously and found that virtually all body organs stained - except the brain. The dye-albumin complex passes freely across capillaries throughout the body but is excluded from the CNS. This selective exclusion defines the blood-brain barrier.
Structural Components
The BBB is not a single structure but a composite of several cellular elements forming the neurovascular unit:
1. Endothelial Cells (the primary barrier)
The BBB resides in the single layer of uninterrupted vascular endothelial cells lining the continuous (non-fenestrated) capillaries of the CNS. These cells differ fundamentally from systemic capillary endothelial cells:
| Feature | Systemic Capillaries | Brain Capillaries |
|---|
| Junctions | Fenestrations / clefts (leaky) | Tight junctions (sealed) |
| Permeability | High - free passage of fluids/solutes | Restricted - transcellular transport only |
| Pinocytosis | Active | Severely restricted |
| Solute passage | Paracellular | Transcellular only |
Tight junctions between brain endothelial cells are structurally more similar to epithelial tight junctions than to those found between ordinary endothelial cells. They eliminate gaps between cells and prevent simple diffusion of solutes and fluid into neural tissue. Substances with a molecular weight greater than 500 Da generally cannot cross the BBB.
Brain capillary (right) vs. systemic fenestrated capillary (left) - note tight junctions vs. fenestrations
2. Basement Membrane
The endothelial cells rest on a continuous basal lamina (basement membrane). Astrocyte end-feet closely associate with this basal lamina, but do not themselves form the physical barrier.
3. Astrocyte End-Feet (Perivascular Feet)
Astrocytes extend end-foot processes that wrap around the outer surface of the capillary and contact the endothelial basal lamina. Although the end-feet do not physically block passage, they:
- Maintain the integrity of the tight junctions (the BBB depends on normal astrocyte function)
- Release soluble factors that increase barrier properties and tight junction protein content
- Regulate water homeostasis via aquaporin-4 (AQP4) water channels in the end-feet
- Buffer extracellular K+ concentration
Breakdown of the BBB in disease is associated with loss of tight junctions AND alterations in astrocyte morphology.
4. Pericytes
Pericytes are embedded within the basement membrane alongside the endothelium. They regulate capillary diameter, contribute to tight junction formation, and participate in immune surveillance.
The neurovascular unit: endothelial cells with tight junctions, basement membrane, pericytes, astrocyte foot processes, and adjacent neuron.
Development
The BBB develops early in the embryo through an interaction between glial astrocytes and capillary endothelial cells. The astrocyte-endothelial signaling relationship is essential both for establishment and maintenance of barrier properties.
Functions
The BBB serves three main roles:
- Protection - excludes blood-borne toxins, pathogens, immune mediators, and fluctuating levels of hormones/amino acids (e.g., dietary amino acids that act as neurotransmitters would cause chaos if freely entering the brain)
- Metabolic supply - active transport of glucose, amino acids, ions, nucleotides, and vitamins into the CNS
- Homeostasis - maintains the optimal ionic microenvironment for neuronal function (e.g., controlling K+ and H+ levels that would otherwise alter membrane potentials)
Transport Across the BBB
Passage across the BBB is tightly controlled:
| Mechanism | Substances |
|---|
| Free diffusion | O2, CO2, lipid-soluble molecules (ethanol, steroid hormones) |
| Facilitated transport (SLC superfamily) | Glucose via GLUT1, cationic amino acids via SLC7A1 |
| Active efflux (ABC transporters) | Drugs, toxins, metabolic waste - transported OUT against concentration gradient |
| Receptor-mediated transcytosis | Insulin, transferrin, large proteins |
| Enzymatic metabolism | Drugs and foreign proteins metabolized within endothelial cell membrane |
Clinical example: Dopamine cannot cross the BBB, so dopamine deficiency (Parkinson's disease) is treated with its precursor L-DOPA, which does cross via amino acid transporters. L-DOPA is then converted to dopamine within the brain.
Blood-CSF Barrier (a related but distinct barrier)
The choroid plexus presents a separate but related barrier:
- Choroid plexus capillaries are fenestrated (leaky), unlike brain capillaries
- The barrier here is formed by the choroid plexus epithelial cells linked by tight junctions (not the capillary wall)
- This blood-CSF barrier regulates CSF composition
Similarly, arachnoid villi allow one-way bulk flow of CSF into venous sinuses via giant vacuoles.
Circumventricular Organs - Areas Lacking a BBB
Several midline structures bordering the 3rd and 4th ventricles are outside the BBB. These are supplied by fenestrated (leaky) capillaries:
| Circumventricular Organ | Function |
|---|
| Area postrema | Chemoreceptor trigger zone (vomiting) |
| Posterior pituitary | Hormone release (ADH, oxytocin) |
| Median eminence | Hypothalamic-pituitary portal signaling |
| Organum vasculosum of lamina terminalis (OVLT) | Osmoreception, fluid balance |
| Subfornical organ | Angiotensin sensing, fluid balance |
| Subcommissural organ | CSF composition |
| Pineal gland | Melatonin secretion |
At these sites, ependymal cells overlying the leaky capillaries (especially at the choroid plexus, median eminence, and area postrema) are joined by tight junctions that form a local BECF-CSF barrier, preventing the variability of blood composition from reaching the CSF.
BBB Breakdown in Disease
Loss of tight junctions and astrocyte dysfunction characterize BBB disruption in:
- Stroke / ischemia
- Multiple sclerosis
- Meningitis / encephalitis
- Brain tumors
- Alzheimer's disease
- Traumatic brain injury
Sources: Neuroanatomy through Clinical Cases, 3rd Ed. | Histology: A Text and Atlas, 9th Ed. | Medical Physiology (Boron & Boulpaep)
Recent review: A 2025 review in
Brain (
PMID 39969549) covers current understanding of the BBB as both a protective barrier and a hindrance to CNS drug delivery, reinforcing the anatomical principles above.